Manjun Hao
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Intravenous Tenecteplase Prior to Endovascular Treatment for Ischemic Stroke at 4.5 to 24 Hours: The TNK-PLUS Randomized Clinical Trial.
Journal: JAMA
Published: May 08, 2026
Infarct growth rate and tenecteplase benefit in ischemic stroke at 4.5 to 24 h without thrombectomy-A secondary analysis of the TRACE-III randomized trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: April 07, 2026
Infarct Growth Rate and Tenecteplase Benefit in Ischemic Stroke at 4.5 to 24 Hours Without Thrombectomy --A Secondary Analysis of the TRACE-Ⅲ Randomized Trial.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: April 07, 2026
The Role of Stroke Severity in the Association between Hypoperfusion Intensity Ratio and Futile Reperfusion after Endovascular Treatment.
Journal: European neurology
Published: December 26, 2025
Clinical benefit of tenecteplase despite failed recanalization in late-window ischemic stroke: a post hoc analysis of the TRACE-3 trial.
Journal: BMC medicine
Published: December 23, 2025
Hypoperfusion Intensity Ratio is Correlated With the Risk of Futile Reperfusion After Endovascular Treatment.
Journal: Academic radiology
Published: November 27, 2025
Tenecteplase for Ischemic Stroke due to Large Vessel Occlusion at 4.5 to 24 Hours: A Meta-Analysis of Randomized Controlled Trials.
Journal: Brain and behavior
Published: November 22, 2025
Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial.
Journal: Lancet (London, England)
Published: November 06, 2025
Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy.
Journal: The New England journal of medicine
Published: June 17, 2024
Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Journal: Journal of the American Heart Association
Published: April 30, 2024
Tenecteplase versus alteplase for acute ischaemic stroke in the elderly patients: a post hoc analysis of the TRACE-2 trial.
Journal: Stroke and vascular neurology
Published: December 18, 2023
Last Updated: 09/26/2026